IL13 and chronic myelogenous leukemia, BCR-ABL1 positive: In dLN, 115 enriched canonical pathways were found (p-value < 0.01), including pathways like WNT/β-catenin signaling, chronic myeloid leukemia signaling, the CDX gastrointestinal cancer signaling pathway, IL-12 signaling and production in macrophages, Th1 and Th2 activation, IL-7 signaling, and IL-4 and IL-13 signaling.